Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016 (2016), Article ID 1536281, 4 pages
http://dx.doi.org/10.1155/2016/1536281
Case Report

Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature

Department of Obstetrics & Gynaecology, PGIMER, Chandigarh 160012, India

Received 31 July 2015; Revised 28 January 2016; Accepted 31 January 2016

Academic Editor: Michael Geary

Copyright © 2016 Minakshi Rohilla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Espinal, A. Laszlo, L. Simonsen et al., “Global trends in resistance to antituberculosis drugs,” The New England Journal of Medicine, vol. 344, no. 17, pp. 1294–1303, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Mahadev, P. Kumar, S. P. Agarwal, L. S. Chauhan, and N. Srikantaramu, “Surveillance of drug resistance to antituberculosis drugs in districts of Hoogli,” Indian Journal of Tuberculosis, vol. 52, no. 1, pp. 5–10, 2005. View at Google Scholar
  3. C. N. Paramasivan, R. Venkataraman, V. Chandrasekaran, S. Bhat, and R. R. Narayanan, “Surveillance of drug resistance in tuberculosis in two districts of South India,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 6, pp. 479–484, 2002. View at Google Scholar · View at Scopus
  4. Central TB Division, Directorate General of Health Services, and Ministry of Health & Family Welfare, DOTS-Plus Guidelines FEB-2009, Revised National Tuberculosis Control Programme, New Delhi, India, 2009.
  5. S. Shin, D. Guerra, M. Rich et al., “Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases,” Clinical Infectious Diseases, vol. 36, no. 8, pp. 996–1003, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Palacios, R. Dallman, M. Muñoz et al., “Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru,” Clinical Infectious Diseases, vol. 48, no. 10, pp. 1413–1419, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Gupta, U. Nayak, M. Ram et al., “Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002–2005,” Clinical Infectious Diseases, vol. 45, no. 2, pp. 241–249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Zvandasara, J. W. Hargrove, R. Ntozini et al., “Mortality and morbidity among postpartum HIV-positive and HIV-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin A supplementation,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 1, pp. 107–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Centers for Disease Control and Prevention, “Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994,” MMWR Recommendations and Reports, vol. 43, no. RR13, pp. 1–132, 1994. View at Google Scholar
  10. N. K. Jain, “Safety of anti-tuberculosis drugs in pregnancy,” in Proceedings of the National Conference on Pulmonary Diseases (NAPCON '01), vol. 33, Mumbai, India, November 2001.
  11. S. Kishan and S. Kaur, “Tuberculosis and pregnancy,” in Proceedings of the National Conference on Pulmonary Diseases (NAPCON '01), Mumbai, India, November 2001.
  12. P. Tabarsi, P. Baghaei, M. Mirsaeidi et al., “Multi-drug resistant tuberculosis in pregnancy: need for more intensive treatment,” Infection, vol. 35, no. 6, pp. 477–478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. C. Drobac, H. del Castillo, A. Sweetland et al., “Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents,” Clinical Infectious Diseases, vol. 40, no. 11, pp. 1689–1692, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Hamadeh and J. Glassroth, “Tuberculosis and pregnancy,” Chest, vol. 101, no. 4, pp. 1114–1120, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Khan, T. Pillay, J. Moodley, A. Ramjee, and N. Padayatchi, “Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa,” International Journal of Tuberculosis and Lung Disease, vol. 11, no. 6, pp. 706–708, 2007. View at Google Scholar · View at Scopus
  16. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India, Central TB Division, Directorate General of Health Services, Ministry of Health, May 2012.
  17. C. R. Lowe, “Congenital defects among children born to women under supervision or treatment for pulmonary tuberculosis,” British Journal of Preventive & Social Medicine, vol. 18, pp. 14–16, 1964. View at Google Scholar · View at Scopus
  18. E. A. Wilson, T. J. Thelin, and P. V. Ditts Jr., “Tuberculosis complicated by pregnancy,” American Journal of Obstetrics & Gynecology, vol. 115, no. 4, pp. 526–529, 1973. View at Google Scholar
  19. B. Bar-Oz, M. E. Moretti, R. Boskovic, L. O'Brien, and G. Koren, “The safety of quinolones—a meta-analysis of pregnancy outcomes,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 143, no. 2, pp. 75–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Schardein, Chemically Induced Birth Defects, Marcel Dekker, New York, NY, USA, 1993.
  21. H. Mittal, S. Das, and M. M. A. Faridi, “Management of newborn infant born to mother suffering from tuberculosis: current recommendations and gaps in knowledge,” Indian Journal of Medical Research, vol. 140, no. 1, pp. 32–39, 2014. View at Google Scholar · View at Scopus